| | | |  | | | | By Adam Feuerstein Elizabeth D. Herman for STAT The study results are preliminary but establish Caribou’s presence among a group of drugmakers leveraging genome-editing technologies. Read More | | By Adam Feuerstein After years of delays and excuses, the company disclosed final results from a late-stage clinical trial of its personalized cancer vaccine. Read More | | By Adam Feuerstein SEBASTIEN BOZON/AFP via Getty Images The outcome is a significant blow to the Swiss pharma giant’s effort to develop the most important cancer drug in its research pipeline. Read More | | Sponsor content by PHARMACYCLICS, AN ABBVIE COMPANY AND JANSSEN ONCOLOGY Examining CLL: Personal experiences driving treatment research Chronic lymphocytic leukemia (CLL) is the most common form of leukemia in adults in the U.S., accounting for 38 percent of all leukemia diagnoses. Every patient with CLL is unique and a one-size-fits-all approach does not work when it comes to treatment. Learn more about CLL from two leaders who are driven by their personal experiences to advance their understanding of this disease. | | By Megan Molteni Pranathi Vemuri/CZ BiohuB and Serena Tan/Stanford "You can think of it as a Google Maps of the human body," a co-chair of the Human Cell Atlas project told reporters. Read More | |
No comments